Group 1 - The core point of the article is that Jiahe Intelligent Technology Co., Ltd. announced a government subsidy of 8 million RMB, which is more than 10% of the company's audited net profit attributable to shareholders for the most recent fiscal year [1][1][1] Group 2 - The subsidy amount exceeds 1 million RMB, indicating significant financial support from the government [1][1][1] - The announcement highlights the company's reliance on government support for its financial performance [1][1][1]

| 证券代码：300793 | 证券简称：佳禾智能 公告编号：2026-005 | | --- | --- | | 债券代码：123237 | 债券简称：佳禾转债 | 佳禾智能科技股份有限公司 关于获得政府补助的公告 一、获取补助的基本情况 按照《企业会计准则第 16 号——政府补助》的规定，与收益相关的政府补 助，用于补偿公司已发生的相关成本费用或损失的，在取得时直接计入当期损 益或冲减相关成本。与公司日常经营相关的政府补助，计入其他收益或冲减相 关成本费用。 （三）补助对公司的影响 本次收到的政府补助预计对公司经营业绩产生正面影响，预计对公司 2026 年度利润总额影响金额为 800 万元。以上数据未经审计，最终会计处理以及对 公司 2026 年度相关财务数据的影响将以审计机构年度审计结果为准，敬请广大 投资者注意投资风险。 1 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 佳禾智能科技股份有限公司（以下简称"公司"）全资子公司江西佳禾电 声科技有限公司（以下简称"江西佳禾"）于近日收到政府补助人民币 800 万 元，该政府补助与收益相关，政府补助金额占 ...

Group 1 - Tianqi Co., Ltd. has entered the brain-computer interface (BCI) sector by investing in Suzhou Huahui Chip, focusing on high-density flexible neural electrode technology, achieving animal testing stages, and becoming a key player in domestic BCI hardware localization. The developed flexible neural electrode has 1024 channels, with signal acquisition precision and anti-interference capabilities at an internationally advanced level. The company has also completed biocompatibility surface modification technology to reduce inflammation after electrode implantation, with core patents authorized by the National Intellectual Property Administration [1][2][3] - Innovation Medical, through its subsidiary Boling Brain Machine, is one of the first companies in China to commercialize BCI rehabilitation products. The core product, Cyberlink AC5, was officially launched in October 2025, generating sales revenue of 114,000 yuan in 2025. Another product, Cyberlink AM5, has completed multi-center clinical trials and is progressing through the approval process. The company plans to establish five additional clinical cooperation centers to accelerate the application of BCI technology in treating neurological diseases [4][5][6] - iFlytek is a leading company in the non-invasive BCI field, leveraging its artificial intelligence technology to develop BCI collaborative technology. The company has established long-term partnerships with universities for research and development. Its non-invasive BCI system has been piloted in 120 schools nationwide, improving student attention by 30%. In the medical field, a collaboration with Beijing Tiantan Hospital has achieved a 92% accuracy rate in identifying abnormal brain signals for epilepsy [7][8][9] Group 2 - Jiahe Intelligent focuses on the research and mass production of BCI hardware, particularly EEG acquisition devices and core components, serving both consumer and medical-grade markets. The company has achieved large-scale production of EEG acquisition headphones with a signal recognition accuracy of 92%, primarily used in sleep monitoring and attention training. It plans to expand into overseas BCI hardware markets by 2026 [10][11][12] - Tom Cat is the first company in China to apply BCI technology in consumer scenarios, focusing on interactive games and rehabilitation training products. The company launched a mind-controlled game product in 2025, which quickly gained over 500,000 users. It also collaborates with rehabilitation institutions to develop BCI rehabilitation training systems, showing a 35% average improvement in patient motor function scores [13][14][15] - Hanwei Technology, through its subsidiary Weisheng Technology, is a leading company in the EEG sensor field, with an annual shipment of over 2 million units. The company has developed an epilepsy early warning system with an 88% accuracy rate in clinical tests. It also focuses on flexible pressure sensors for invasive BCI electrodes, addressing industry pain points [16][17][18] Group 3 - StarNet Ruijie leverages its network communication technology to develop low-power, high-stability EEG signal transmission systems and data encryption modules, becoming a core supplier for BCI data links. The developed transmission system supports real-time transmission of 1024-channel EEG signals with a latency of less than 10ms and a stability of 99.9% [19][20][21] - Yijiahe focuses on the integration of BCI and embodied intelligent robots, exploring applications in smart healthcare. The company has signed a strategic cooperation agreement to develop real-time emotional companionship and brain-controlled robots, enhancing the emotional care capabilities of robots [22][23][24] - Lihua Technology is focused on incubating and investing in the BCI sector, successfully incubating three high-tech companies in the field. The company collaborates with the Shenzhen Institute of Advanced Technology to provide comprehensive services for incubated companies, addressing development pain points [25][26][27] Group 4 - Sanbo Neurosurgery is a leading private hospital in the neurosurgery field, focusing on the clinical application and research of BCI. The company has successfully conducted an interventional BCI surgery, accumulating valuable experience for clinical applications. It is also recruiting participants for ongoing clinical trials [28][29][30] - Shiyun Circuit is a core enterprise in the PCB field, providing customized PCB products for BCI devices. The company focuses on high-density, flexible PCB designs, achieving low signal loss rates below 2% [31][32][33] - Meihua Medical is a leading supplier of core components for BCI, having entered the core supply chain for invasive BCI products. The company has developed components that have passed biocompatibility tests, ensuring long-term stability and safety for implanted devices [34][35][36]

Group 1 - The company has provided consumer-grade AR product manufacturing services for brands such as Yingmu and Xianshun, with new eyewear products set to be launched at the CES exhibition in January 2026 [2] - Currently, the revenue contribution from eyewear business is relatively low, and specific data will be available in the company's periodic reports [2] - The company has developed various combinations of eyewear products and can offer integrated hardware and software solutions, aiming to deepen communication with new clients and steadily advance business cooperation [2]

Core Viewpoint - The article highlights how the local government in Shangli County, Jiangxi, has successfully attracted five listed companies by enhancing industrial agglomeration, improving the business environment, and increasing investment promotion professionalism, leading to the development of a precision circuit board industry cluster. Group 1: Industrial Agglomeration - Shangli County has developed the Ganshan Cooperation Industrial Park, focusing on electronic information, equipment manufacturing, and food industries, with a notable emphasis on the precision circuit board (PCB) sector, which has been recognized as a provincial-level characteristic industry cluster [2][4]. - Companies prioritize industrial agglomeration when selecting locations for new capacities, as it reduces production costs and fosters a competitive environment among businesses [3]. - The local government has strategically nurtured the PCB industry by attracting upstream and downstream enterprises, enhancing production collaboration within the industrial park [4]. Group 2: Business Environment - The local business environment, including government efficiency and credit systems, is a critical factor for companies when deciding to settle in Shangli [5]. - Shangli County has implemented a full lifecycle management and service mechanism for investment projects, ensuring tailored support for over 100 projects [5]. - Positive experiences with local governance have led to additional investments from companies, indicating their satisfaction with the business environment [5]. Group 3: Investment Promotion Professionalism - The introduction of the "Negative List" in the Fair Competition Review Regulation has prompted local governments to rethink their strategies for attracting and retaining industries [6]. - Professionalism in investment promotion has become crucial, with Shangli County focusing on capital investment and establishing a specialized team for project engagement [7]. - In 2023, Shangli County established Jiangxi Ganshan Investment Company to enhance its investment promotion capabilities, leading to significant projects such as a 2 billion yuan investment in Guoguang Electric Co., Ltd. for establishing a production base [7].

| 证券代码：300793 | 证券简称：佳禾智能 | 公告编号：2026-004 | | --- | --- | --- | | 债券代码：123237 | 债券简称：佳禾转债 | | 佳禾智能科技股份有限公司 2026 年第一次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示 1、 本次股东会不存在否决议案的情形。 4、 召集人：董事会 5、 主持人：严帆先生 6、 本次会议的召集、召开符合《中华人民共和国公司法》《上市公司股 东会规则》《深圳证券交易所创业板股票上市规则》等有关法律、行政法规、部 门规章、规范性文件和《佳禾智能科技股份有限公司章程》的有关规定。 二、会议出席情况 （一）股东出席的总体情况 2、 本次股东会不涉及变更以往股东会已通过的决议。 一、会议召开情况 1、 召开时间：2026 年 1 月 9 日（星期五）15:30 2、 召开地点：广东省东莞市松山湖园区科苑路 3 号佳禾智能科技股份有 限公司会议室 3、 召开方式：现场结合网络 参加本次股东会现场会议和网络投票表决的股东及股东代理人共 395 人，代 表 ...

三、培训时间 2025 年 12 月 24 日 四、培训人员 招商证券股份有限公司 关于佳禾智能科技股份有限公司 2025 年持续督导培训情况报告 招商证券股份有限公司（以下简称"招商证券"或"本保荐机构"） 根据《深 圳证券交易所上市公司自律监管指引第 13 号——保荐业务》的相关规定，对佳 禾智能科技股份有限公司（以下简称"佳禾智能"或"公司"）相关人员进行了 2025 年度持续督导培训，所培训的内容严格按照中国证券监督管理委员会及深圳证券 交易所有关持续督导的最新要求进行，具体报告如下： 一、保荐机构 招商证券股份有限公司 二、保荐代表人 李炎、曹志鹏 本次培训内容主要为上市公司规范运作、募集资金管理和使用的相关规定学 习，上市公司治理准则修订内容解析等。 九、培训总结 曹志鹏（保荐代表人）、王安琪（持续督导专员） 五、培训地点 广东省东莞市松山湖园区科苑路 3 号，佳禾智能总部 六、培训方式 现场授课，部分培训对象通过网络会议软件线上接入 七、参加培训人员 公司董事、高级管理人员及实际控制人等相关人员 八、培训内容 本次持续督导培训的工作过程中，佳禾智能给予了积极配合。保荐机构通过 本次培训，使公司董 ...

广东法制盛邦（东莞）律师事务所 关于 佳禾智能科技股份有限公司 2026 年第一次临时股东会 之 法律意见书 地址：广东省东莞市南城区会展北路东莞会展国际大酒店三楼 邮编：523073 3F, Dongguan Convention & Exhibition International Hotel, Huizhan North Road, Nancheng District, Dongguan, Guangdong, China 电话/Tel: 0769-22313111 传真/Fax: 0769-22502111 电子邮箱/Mail：everwin0769@163.com 网址/Website：http://www.everwin0769.com 二〇二六年一月 广东法制盛邦（东莞）律师事务所 法律意见书 广东法制盛邦（东莞）律师事务所 关于佳禾智能科技股份有限公司 2026 年第一次临时股东会之 法律意见书 致：佳禾智能科技股份有限公司 或用途。本所同意，公司将本法律意见书作为公司本次股东会的公告材料，随其 他需公告的信息一起向公众披露，并依法对本所在其中发表的法律意见承担法律 责任。 本所律师根据现行有 ...

招商证券股份有限公司 | 5.是否不存在关联交易非关联化的情形 | √ | | --- | --- | | 6.对外担保审议程序是否合规且履行了相应的信息披露义务 √ | | | 7.被担保方是否不存在财务状况恶化、到期不清偿被担保债 √ | | | 务等情形 | | | 8.被担保债务到期后如继续提供担保，是否重新履行了相应 √ | | | 的审批程序和披露义务 | | | （五）募集资金使用 | | | 现场检查手段：查阅公司募集资金管理制度、公司三方监管协议、募集资金账户 | | | 对账单、三会资料、鉴证报告等相关资料。 | | | 1.是否在募集资金到位后一个月内签订三方监管协议 | √ | | 2.募集资金三方监管协议是否有效执行 | √ | | 3.募集资金是否不存在第三方占用或违规进行委托理财等情 | √ | | 形 | | | 4.是否不存在未履行审议程序擅自变更募集资金用途、暂时 | √ | | 补充流动资金、置换预先投入、改变实施地点等情形 | | | 5.使用闲置募集资金暂时补充流动资金、将募集资金投向变 | | | √ 更为永久性补充流动资金或者使用超募资金补充流动资金 | | | ...

Core Viewpoint - Jiahe Intelligent has shown a positive stock performance with a year-to-date increase of 9.87% and a recent surge of 11.58% over the last five trading days, indicating strong market interest and potential growth in the consumer electronics sector [1]. Group 1: Stock Performance - As of January 8, Jiahe Intelligent's stock price reached 17.92 CNY per share, with a market capitalization of 6.819 billion CNY [1]. - The stock has seen a trading volume of 1.91 billion CNY, with a turnover rate of 2.90% [1]. - The company experienced a net inflow of main funds amounting to 13.6584 million CNY, with significant buying activity from large orders [1]. Group 2: Financial Performance - For the period from January to September 2025, Jiahe Intelligent reported a revenue of 1.625 billion CNY, reflecting a year-on-year decrease of 15.91% [2]. - The net profit attributable to shareholders was 28.8252 million CNY, down 60.03% compared to the previous year [2]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Jiahe Intelligent was 47,500, a decrease of 9.05% from the previous period [2]. - The average number of circulating shares per shareholder increased by 9.95% to 7,828 shares [2]. - The company has distributed a total of 222.3 million CNY in dividends since its A-share listing, with 146 million CNY distributed over the last three years [3].